Brevan Howard Capital Management’s Organon & Co OGN Stock Holding History

Brevan Howard Capital Management’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-163,067	Closed	-$977K	–	2442
2026 Q1	$977K	Sell	163,067 -53,950	-25%	-$406K	0.01%	910
2025 Q4	$1.56M	Buy	217,017 +160,415	+283%	+$1.27M	0.02%	580
2025 Q3	$605K	Buy	56,602 +22,582	+66%	+$222K	﹤0.01%	1184
2025 Q2	$329K	Buy	34,020 +12,775	+60%	+$132K	﹤0.01%	1511
2025 Q1	$316K	Sell	21,245 -113,957	-84%	-$1.75M	﹤0.01%	848
2024 Q4	$2.02M	Buy	+135,202	New	+$2.2M	0.01%	282
2024 Q2	–	Sell	-21,167	Closed	-$398K	–	1310
2024 Q1	$398K	Sell	21,167 -46,325	-69%	-$795K	﹤0.01%	537
2023 Q4	$973K	Buy	+67,492	New	+$918K	0.01%	241

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Brevan Howard Capital Management's OGN Position: Q2 2026 in Review

Brevan Howard Capital Management sold out of Organon & Co (OGN) in Q2 2026, closing a stake of 163,067 shares — an estimated $977K sold.

Brevan Howard Capital Management first reported a position in OGN in Q4 2023 and held it in 8 quarters. The position peaked at $2.02M in Q4 2024. 627 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

Brevan Howard Capital Management reported no remaining Organon & Co position as of Q2 2026 after selling out during the quarter.
Brevan Howard Capital Management sold 163,067 Organon & Co shares in Q2 2026, an estimated $977K.
Brevan Howard Capital Management first reported a position in Organon & Co in Q4 2023 and held it in 8 quarters.
Brevan Howard Capital Management's Organon & Co position peaked at $2.02M in Q4 2024.
627 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.